Endoparasite control agent

US9447042B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9447042-B2
Application numberUS-201214000974-A
CountryUS
Kind codeB2
Filing dateMar 1, 2012
Priority dateMar 2, 2011
Publication dateSep 20, 2016
Grant dateSep 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): or a salt thereof as an active ingredient, and a method for controlling endoparasites, comprising orally or parenterally administering the endoparasite control agent.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for controlling endoparasites, wherein the endoparasite is selected from the subclass Rhabditia or Spiruria, in a mammal or bird, comprising orally or parenterally administering an effective amount of the endoparasite control agent comprising a carboxamide derivative represented by the general formula(I): wherein A represents a (C 1 -C 2 ) alkylene group which is optionally substituted by a (C 1 -C 6 ) alkyl group and/or a (C 3 -C 6 ) cycloalkyl group E represents a hydrogen atom, each X may be the same or different, and represents a halogen atom; or a (C 1 -C 6 ) alkyl group optionally substituted by a halogen atom; m represents an integer of 0, 1 or 2, each Y may be the same or different, and represents a halogen atom; a (C 1 -C 6 ) alkyl group optionally substituted by a halogen atom; n represents an integer of 0, 1, 2 or 3 and Z represents CH; or CY (wherein Y is as defined above), or a salt thereof as an active ingredient to said mammal or a bird. 2. The method according to claim 1 , wherein an effective amount of the endoparasite control agent is administered to a mammal. 3. The method according to claim 2 , wherein the mammal is a domestic animal. 4. The method according to claim 2 , wherein the mammal is human. 5. The method according to claim 1 , wherein m represents 1 or 2. 6. The method according to claim 1 , wherein m represents 1, each Y may be the same or different, and represents a halogen atom or a (C 1 -C 6 )alkyl group optionally substituted by a halogen atom, and n represents an integer of 1 to 3. 7. The method according to claim 1 , wherein the carboxamide derivative represented by the general formula (I) is a compound of the formula: 8. The method according to claim 1 , wherein the endoparasite is Haemonchus contortus.

Assignees

Inventors

Classifications

  • Anthelmintics · CPC title

  • Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis · CPC title

  • Antimalarials · CPC title

  • Amoebicides · CPC title

  • Antiparasitic agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9447042B2 cover?
Provided are an endoparasite control agent comprising a carboxamide derivative represented by the general formula (I): or a salt thereof as an active ingredient, and a method for controlling endoparasites, comprising orally or parenterally administering the endoparasite control agent.
Who is the assignee on this patent?
Kita Kiyoshi, Suwa Akiyuki, Univ Tokyo, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61K31/44. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).